Form 4: Heartflow Director Acquires Stock Options

Heartflow, Inc. director Timothy C. Barabe acquired 16,075 stock options with an exercise price of $32.05, vesting in full by June 2027.

Summary

• Timothy C. Barabe, a Director at Heartflow, Inc., acquired 16,075 stock options on June 16, 2026.
• The options have an exercise price of $32.05 per share.
• These options are set to vest in full on the earlier of the day prior to Heartflow's annual shareholder meeting in 2027 or the first anniversary of the grant date, contingent upon continued service.
• The underlying securities are common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard stock option grant to a director, which is typical compensation and not indicative of immediate positive or negative company performance.

Positives

• Director acquisition of stock options can signal confidence in the company's future prospects.
• The vesting schedule encourages continued service and alignment with shareholder interests.

Future Outlook

The stock options are exercisable until June 16, 2036, with full vesting expected by 2027, subject to continued service.

Industry Context

StockSavvy.ai notes that director stock option grants are a common form of executive compensation and incentive alignment within the biotechnology and medical device sectors, where Heartflow operates. Such grants are often tied to performance and continued employment.

Stakeholder Impact

• Shareholders: The grant of options to a director aligns their interests with shareholders, potentially encouraging actions that benefit the company's stock price. However, the dilutive effect of future share issuance upon exercise should be considered.

Next Steps

• Timothy C. Barabe may exercise the vested stock options at his discretion until June 16, 2036.
• The options will fully vest by the earlier of the day prior to Heartflow's annual shareholder meeting in 2027 or the first anniversary of the grant date, provided continued service.

Key Dates

Keywords

Heartflow, HTFL, Form 4, Stock Options, Director, Beneficial Ownership, Securities Exchange Act